Trademark Attorney / Law Firm
Brad Englund – Trademark Portfolio
Brad Englund has filed 7 trademarks with the United States Patent and Trademark Office (USPTO). Filing records are from 2009. Of these filings, 1 is currently registered. The portfolio covers 7 Nice Classification classes, with the highest concentration in Class 31 (Natural Agricultural Products, 3 filings) and Class 5 (Pharmaceuticals, 2 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
Brad Englund's trademark practice covers 7 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademark applications has Brad Englund filed?
Brad Englund has filed 7 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 3 abandoned, 3 cancelled.
What trademark classes does Brad Englund specialize in?
Brad Englund has filed trademarks across 7 Nice Classification classes. The most common practice areas include Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What is Brad Englund's trademark registration success rate?
Brad Englund has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.